Last reviewed · How we verify

NCT03882515

Evaluation Of Peripheral Muscle Oxygenation In Individuals With Muscular Idiopathic Pain With Myofascial Release

Completed NA Last updated 25 September 2019
What this trial tests

NA trial testing Myofascial Release in Trapezius Muscle Strain in 126 participants. Completed in 30 July 2019.

Timeline
31 August 2017
Primary endpoint
14 March 2019
30 July 2019

Quick facts

Lead sponsorUniversity of the State of Santa Catarina
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment126
Start date31 August 2017
Primary completion14 March 2019
Estimated completion30 July 2019
Sites1 location across Brazil

Drugs / interventions tested

Conditions studied

Sponsor

University of the State of Santa Catarina

Who can join

18 and older, any sex, with Trapezius Muscle Strain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Introduction: Neck Pain (NP) is considered a common idiopathic disorder in the general population. Oriented from incorrect executions during daily activities the DPO compromises the trapezius muscle that has a viscoelastic coating called fascia, which, in turn, is a soft tissue component, belonging to the connective tissue, that permeates the entire human body. During some activities that generate muscle overload, the fascia may undergo energy demands in which the local blood supply may be decreased, causing tissue hypoxia to result in pain. Decreased tissue blood supply could limit or prevent slippage of myofascial tissues. However, myofascial release can influence mechanoreceptors within the fascia, contributing to changes in local fluid dynamics, reducing excessive muscle tension, capillary constriction, and increasing local blood flow. One of the tools available for hemodynamic evaluation is the Near Infrared Spectroscopy (NIRS), which can quantify and capture variations in hemoglobin levels. Aim: To investigate whether myofascial release improves peripheral muscle oxygenation, pain intensity, and functional capacity of individuals with trapezius muscle pain. Methods: It is a clinical, parallel, randomized, double blind controlled trial with three groups that will be divided into: experimental, Sham and control. The instruments to be used in the research will be: Pressure Algometer, Neck Disability Index Questionnaire, Visual Analogue Scale (VAS), NIRS and Electromyograph. The experimental group will receive a myofascial release protocol for 20 minutes once weekly for six weeks. The Sham group will receive a continuous surface slip technique for the same time and frequency and the control will perform the evaluation and re-evaluation. Results: The present research is expected to increase peripheral muscle oxygenation, decrease pain threshold and improve quality of life after 6 weeks of intervention.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Peripheral muscle oxygenation, pain, and disability indices in individuals with and without nonspecific neck pain, before and after myofascial reorganization®: A double-blind randomized controlled trial.
    Dos Santos Amorim M, Sinhorim L, Baptistella do Nascimento I, Wagner J, et al · · 2024 · cited 2× · PMID 38335169 · DOI 10.1371/journal.pone.0292114

Verify or expand the search:

Other trials of Myofascial Release

Trials testing the same drug.

Other recruiting trials for Trapezius Muscle Strain

Currently open trials in the same condition.

Other University of the State of Santa Catarina trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03882515.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing